Amylin is a 37 amino acid neurohormone co-secreted with insulin by pancreatic β-cells after a meal and its levels are reduced in T1D, and pramlintide is a synthetic analogue of amylin that was approved in April 2004 by the FDA [218]. This evidence concerns the gene INS and type 1 diabetes mellitus.